A Quote by Thomas Pogge
In the domain of pharmaceuticals, we need a metric for health impact, and with this metric we can then assess the value of the introduction of a new product and pay its innovator accordingly, say on the basis of the product's measured health impact during its first ten years on the market. In exchange, innovators must of course renounce the usual rewards they are otherwise entitled to, namely the patent-protected markup on the price of their product.
Related Quotes
With the Health Impact Fund, the innovation is paid for separately, through publicly funded health impact rewards, and the product is sold at the cost of production to all. Here, the cruel injustice of preventing the poor from buying at cost - evidenced by today's suppression of the trade in generic versions of patented medicines - would no longer be needed.
I've been told I miss every pass made at me! It would be wonderful to have a partner, but in my mind, it has to be like making a product. The product has to be meaningful, impact people - it has to be a great product.
If the Health Impact Fund were to be instituted, a single company would be in charge of a medical product all the way from its conception to the health improvements realized by actual patients. The company would be paid for health impact, and it would have to arrange the entire pipeline in between - all the steps of invention, of clinical testing, of getting marketing approval in many different countries, of wholesalers and retailers and prescriptions and so on - in a holistically optimal way.
I've always believed that the best way you combat intellectual property theft is making a product available that is well priced, well timed to market, whether it's a movie product, TV product, music product, even theme-park product.
Process innovation is different from product innovation. It's about how do you create a new product or develop a new product or manufacture a new product, but not a new product itself?
Internet and mobile product development cycles are measured in months, not years. And the capital required to get a product built and into the market is less than $1 million. And the returns, when things work out, can be enormous.
To improve global health, it's not enough just to have a really good new product and to obtain marketing approval. You still need to market the product and bring it to patients, follow up, create the infrastructure, and so on - the whole pipeline, the network. That's something that companies are extremely good at: organizing a whole pipeline in a cost-effective way.
You could place one product in a first-run telecast, a second product what that program is rerun, and a third product when the show goes into syndication, and another product when it goes on cable.
If you think of the product as a service, then the separate parts make no sense - the point of a product is to offer great experiences to its owner, which means that it offers a service. And that experience, that service, comprises the totality of its parts: The whole is indeed made up of all of the parts. The real value of a product consists of far more than the product's components.
We have this highly irrational system of incentivizing innovation for clean and green technologies, where we allow the innovator to have a temporary monopoly and then mark up the price of the product or sell licenses at high prices to those who want to use the kind of product that the innovator has invented. This system is collectively irrational because many people, to avoid the inflated prices of still-patented cleaner and greener technologies, opt for some older technology that is much more polluting.
The war on drugs - a big-government product if there ever was one - has been wildly unsuccessful, by any metric.
The normal metric of measuring progress has actually been the rate of growth, OK? It's not a wrong metric, but it's not a full metric.
The value of money comes from the private sector in the form of price for product, services rendered, what people are willing to pay for something they want or need. That's where value happens. Government has nothing to do with that.
Some analysts think people come into our shops and then go and buy the product on the Internet, but the manufacturer knows if the customer can't see the product and assess it, they won't buy.
New product and new types of service are generated, not by asking the consumer, but by knowledge, imagination, innovation, risk, trial and error on the part of the producer, backed by enough capital to develop the product or service and to stay in business during the learn months of introduction.
Traditional sales and marketing involves increasing market shares, which means selling as much of your product as you can to as many customers as possible. One-to-one marketing involves driving for a share of customer, which means ensuring that each individual customer who buys your product buys more product, buys only your brand, and is happy using your product instead of another to solve his problem. The true, current value of any one customer is a function of the customer's future purchases, across all the product lines, brands, and services offered by you.
Related Authors
Alan Watts Quotes
English
Philosopher
Albert Camus Quotes
French
Philosopher
Aristotle Quotes
Greek
Philosopher
Arthur Schopenhauer Quotes
German
Philosopher
Blaise Pascal Quotes
French
Philosopher
Confucius Quotes
Chinese
Philosopher
Francis Bacon Quotes
English
Philosopher
Friedrich Nietzsche Quotes
German
Philosopher
Jiddu Krishnamurti Quotes
Indian
Philosopher
Laozi Quotes
Chinese
Philosopher
Michel de Montaigne Quotes
French
Philosopher
Plato Quotes
Greek
Philosopher
Ralph Waldo Emerson Quotes
American
Philosopher
Seneca the Younger Quotes
Roman
Philosopher
Thomas Carlyle Quotes
Scottish
Philosopher
William James Quotes
American
Philosopher